Sir, A recent review by Smith et al.1 and associated correspondence2,3 raised important unresolved issues regarding which quinolones exert dual activity through gyrase and topoisomerase IV in Streptococcus pneumoniae. Dual action involves the substantial engagement of both enzyme killing pathways and is of particular interest in potentially limiting the emergence of resistance. Smith et al.3 co...

DC-159a yielded MICs of or=4 microg/ml). Although the MICs for DC-159a against quinolone-susceptible pneumococci were a few dilutions higher than those of gemifloxacin, the MICs of these two compounds against 28 quinolone-resistant pneumococci were identical. ...

a simple, precise, inexpensive and sensitive voltammetric method has been developed for the determination of gemifloxacin mesylate (gem) in the presence of tween 80 in the bulk, farmaceutical dosage forms and human urine at gold nanoparticles modified carbon paste electrode (gncpe). the electrochemical behavior of gem has been investigated by using cyclic voltammetry (cv) and differential pulse...

Synthesis and biological evaluation of the 99mTcN-Gemifloxacin dithiocarbamate (99mTcN-GIND) complex was investigated in terms of radiochemical stability (RCP) in saline, serum, in-vitro binding with Streptococcus pneumoniae (S. pneumoniae) and biodistribution in male Wistar rats artificially infected with living and heat killed S. pneumoniae. The maximum RCP was 98.25 ± 0.30% at 30 min and dec...

Sir, BMS-284756 (T-3811) is a novel quinolone that lacks a fluorine at the C-6 position, and is active in vitro against Streptococcus pneumoniae, including strains with elevated ciprofloxacin MICs. Because the various quinolones differ in both target affinity and their activation of efflux pumps, one can speculate that the phenotypic expression of quinolone resistance will also differ. Studies ...

BACKGROUND Eradication of Helicobacter pylori infection plays a crucial role in the treatment of peptic ulcer. Clarithromycin resistance is a major cause of treatment failure. This randomized clinical trial aimed at evaluating the efficacy of a clarithromycin versus gemifloxacin containing quadruple therapy regimen in eradication of H.pylori infection. METHODS In this randomized double blind cl...

The incidence of penicillin resistance in pneumococci is increasing in the USA, having risen from <5% before 1989 to >35% in 1997. There has also been a shift in the ratio of intermediate to high-level resistance from 3 or 4:1 to 2 or 1:1. Multidrug resistance and resistance to macrolides and fluoroquinolones in pneumococci is also a matter of concern. The implications for empirical treatment o...